In This Section

Nancy Zahniser Memorial Symposium: The Dopamine Transporter in Health and Disease

Sunday April 22, 2018

9:30 am - 12:00 pm

Room 16B
Sponsored by the Division for Neuropharmacology (NEU)
Co-sponsored by the Division for Behavioral Pharmacology (BEH)
Co-sponsored by the Division for Pharmacology Education (DPE)

Chair :

Habibeh Khoshbouei
University of Florida

Lynette Daws
University of Texas Health Science Center at San Antonio

Dr. Zahniser pioneered research elaborating our understanding of how dopamine and glutamate contribute to individual differences in cocaine-induced brain plasticity and addiction-like behavior, and how dopamine transporters are rapidly regulated. Her findings underscore the overall importance of dopamine transporters in contributing to enhanced vulnerability to cocaine addiction and relapse. Dr. Zahniser was strongly committed to mentoring young scientists, and to ASPET. In tribute of her many accomplishments, this symposium captures the most recent advances in understanding dopamine transporter function and regulation, and its important role in health, disease, and addiction. Importantly, this symposium highlights novel targets for treating dopamine-linked pathologies.

Dopamine Transporters and Psychostimulant Action: Lessons from Nancy
Susan Amara - NIMH

Dopamine Transporters: Linking Obesity to Diabetes to Psychiatric Disorders
Aurelio Galli - University of Alabama-Birmingham

Altered Dopamine Transporter Function and Immunoregulation in PD Macrophages
Phillip Mackie - University of Florida

An Unsuspected Role for Organic Cation Transporter 3 in the Actions of Amphetamine
Felix Mayer - Institute of Pharmacology, Medical University of Vienna

DATS Not All: Organic Cation Transporters in the Actions of Psychoactive Drugs
Lynette Daws - University of Texas Health Science Center at San Antonio

Modulation of Stimulant Actions by the Intertwining Activities of D2 Autoreceptors and PKCbeta
Margaret Gnegy - University of Michigan

Moving from Neuronal Transporter Structures to Clinically Relevant Therapeutics for Neurodegenerative Disorders
Ulrik Gether - University of Copenhagen

Thank you to our Annual Meeting partners:

University of Florida
Wake Forest University
Washington State University College of Pharmacy and Pharmaceutical Sciences
University of Wisconsin Molecular and Cellular Pharmacology Training Program
UT Health San Antonio
University of Minnesota

Emory University Pharmacology

PR & P
University of Michigan Medical School Pharmacology